| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |